Acest studiu a avut ca scop studierea activității antiproliferative a complexului (cloro(N-fenil-N'-[(piridin-2-il)me­ti­li­den]carbamohidrazontiolato)(4-aminobenzen-1-sulfonamid)-cupru) pe linii de celule cancerigene. S-a stabilit că com­ple­xul investigat cu cupru (II) prezintă cea mai mare activitate anticancerigenă împotriva celulelor liniilor MeW-164, HeLa, BxPC-3 și RD cu valori IC50 de 1,0±0,2, 0,4±0,04, 1,7±0,2, 1,3±0,3, respectiv. Studiul comparativ al compusului tes­tat cu DOXO în ceea ce privește liniile de celule cancerigene a arătat că complexul testat de cupru (II) prezintă o activitate inhibitoare mai puternică asupra proliferării celulelor cancerigene decât doxorubicina și cisplatina.


complex mixt-ligand, doxorubicină, cisplatină, activitate anticancerigenă, linii de celule cancerigene

Full Text:



FURUI, T., TAKAI, Y., et al. Fertility preservation in adolescent and young adult cancer patients: From a part of a national survey on oncofertility in Japan. In: Reprod. Med. Biol., 2018 Nov 20; 18(1):97-104. doi: 10.1002/ rmb2.12256. Collection 2019 Jan.

SHABALALA, S., DLUDLA, P., MULLER, C., NXELE, X., KAPPO, A., LOUW, J., JOHNSON, R. Aspalathin ameliorates doxorubicin-induced oxidative stress in H9c2 cardiomyoblasts. In: Toxicol In Vitro., 2019 Mar; 55:134-139. doi: 10.1016/j.tiv.2018.12.012. Epub 2018 Dec 19. PMID: 30576852

CHANG, A., ASKARI, M., et al. Association of Healthcare Plan with atrial fibrillation prescription patterns. In: Clin. Cardiol., 2018 Sep; 41(9):1136-1143. doi: 10.1002/clc.23042. Epub 2018 Sep 22. PMID: 30098034

TACAR, O., SRIAMORNSAK, P., DASS, R. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. In: J. Pharm. Pharmacol., 2013 Feb; 65(2):157-70. doi: 10.1111/j.2042-7158.2012. 01567.x. Epub 2012 Aug 2.

CARRESI, C., MUSOLINO, V., GLIOZZI, M., MAIUOLO, J., et al. Anti-oxidant effect of bergamot polyphe¬nolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kitposCD45neg CD31neg cardiac stem cell activation. J. Mol. Cell. Cardiol., 2018 Jun; 119:10-18. doi: 10.1016/j.yjmcc. 2018.04.007. Epub 2018 Apr 12. PMID:29654879

KELLAND, L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin. Cancer. Res., 2007 Sep 1; 13(17):4960-3. Review.PMID:17785545

DENOYER, D., MASALDAN, S., LA FONTAINE, S., CATER, M. Targeting copper in cancer therapy: 'Copper That Cancer'. In: Metallomics, 2015 Nov; 7(11):1459-76. doi: 10.1039/c5mt00149h. Epub 2015 Aug 27. Review. PMID:26313539

HUFSCHMIDT, K., BOZEC, A., et al. Versatility of cervicofacial flaps: Cervical-medial cheek flap for reconstruction in cutaneous substance loss of the inner cheek. In: Head Neck., 2018 Dec; 40(12):2574-2582. doi: 10.1002/hed.25183. Epub 2018 Nov 17. PMID:30447111

BARRERA, L., COOREMAN, E., et al. Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs. Geneva: World Health Organization; 2008.PMID:26290924.

SANTINI, C., PELLEI, M., et al. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands. In: J. Inorg. Biochem., 2011 Feb; 105(2):232-40. doi: 10.1016/j.jinorgbio.2010.10.016. Epub 2010 Nov 5. PMID:21194623

SIANI, L.M., FERRANTI, F., et al. Laparoscopic total mesorectal excision for extraperitoneal rectal cancer. Oncological outcome at 5 years. In: Chir. Ital., 2009 Sep-Dec; 61(5-6):585-9. Italian. PMID:20380262

YU, Y. J MED CHEM. Thiosemicarbazones from the old to new: iron chelators that are more than just ribo-nucleotide reductase inhibitors, 2009. Review Article PMID: 19601577

PAHONȚU, E., PARASCHIVESCU, C., et al. Synthesis and Characterization of Novel Cu(II), Pd(II) and Pt(II) Complexes with 8-Ethyl-2-hydroxytricyclo(,7))tridecan-13-one-thiosemicarbazone: Antimicrobial and in Vitro Antiproliferative Activity. In: Molecules, 2016 May 21; 21(5). pii: E674. doi: 10.3390/molecules210 50674.

ZHANFEN, C., YIXUAN, W., et al. DNA cleavage, DNA/HSA binding study, and antiproliferative activity of a phenolate-bridged binuclear copper(II)complex.

ALI, I., SHAH, M., YOUSUF, S., AHMED, S., SHAH, K., JAVED, I. Hemolytic and cellular toxicology of a sulfanilamide-based nonionic surfactant: a niosomal carrier for hydrophobic drugs. In: Toxicol. Res. (Camb)., 2018 Jun 13; 7(5):771-778. doi: 10.1039/c8tx00108a. Collection 2018 Sep 1. PMID: 30310655

PAHONTU, E., FALA, V., GULEA, A., et al. Synthesis and Characterization of Some New Cu(II), Ni(II) and Zn(II) Complexes with Salicylidene Thiosemicarbazones: Antibacterial, Antifungal and in Vitro Antileukemia Activity. In: Molecules, 2013, 18, 8812-8836; doi:10.3390/molecules18088812


  • There are currently no refbacks.